Hybridoma cell line g250 and its use for producing...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/20 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01)

Patent

CA 2435683

The invention relates to a hybridoma cell line which is capable of producing the monoclonal antibody G250. Furthermore, the invention describes the method of employing such cell line for the production and manufacture of monoclonal antibody G250 as well as derivatives thereof such as chimeric and humanized G250 antibodies.

L'invention porte sur une lignée de cellules d'hybridomes capable de produire l'anticorps monoclonal G250 et sur un procédé d'utilisation de ladite lignée de cellules en vue de la production et de la fabrication de l'anticorps monoclonal G250 et de ses dérivés tels que des anticorps G250 chimères et humanisés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hybridoma cell line g250 and its use for producing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybridoma cell line g250 and its use for producing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma cell line g250 and its use for producing... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1604684

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.